首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1629816

全球動脈瘤夾市場 - 2024-2031

Global Aneurysm Clips Market - 2024-2031

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2023年，全球動脈瘤夾市場規模達52.4億美元，預計2031年將達到103.1億美元，2024-2031年預測期間複合年成長率為8.9%。

動脈瘤夾是用於治療腦動脈瘤的專用手術設備，腦動脈瘤是由大腦中受損的動脈血引起的隆起。這些夾子通常由鈦製成，旨在在稱為動脈瘤夾閉的外科手術過程中插入動脈瘤頸部。這些夾子的基本功能是將動脈瘤與正常血流隔離，有效地將其封閉並防止其充滿血液。這項手術至關重要，因為動脈瘤破裂可能會導致嚴重後果，例如出血性中風，從而增加死亡或終身殘疾的風險。

全球動脈瘤夾市場的主要驅動力是由於外科手術中對夾子的需求增加、腦動脈瘤盛行率的增加以及改進的鈦合金在夾子中的使用。此外，夾子具有薄刀片形狀，並且相容於 MRI，可保護組織完整性。雖然動脈瘤夾閉手術已被證明在治療動脈瘤方面是安全有效的，但它是一種侵入性手術，需要全身麻醉和顱骨解剖。

市場動態：

驅動程式和限制

腦動脈瘤盛行率增加

腦動脈瘤盛行率的增加預計將成為全球動脈瘤夾市場成長的重要因素。腦動脈瘤盛行率的增加預計將對全球動脈瘤夾市場的成長產生重大影響。腦動脈瘤是指大腦動脈局部擴張，會造成嚴重的健康危害，包括破裂和隨後出血的可能性。隨著人們越來越意識到這些問題以及醫療技術的進步，對動脈瘤夾等有效治療方案的需求預計將會增加。隨著老年人口的不斷增加和與生活方式相關的健康狀況的增加導致發病率上升，除了手術設備的技術進步之外，預計未來幾年對動脈瘤夾的需求將顯著增加。

腦動脈瘤盛行率的增加是推動市場的主要因素。例如，根據腦動脈瘤基金會的統計，美國估計有 680 萬人患有未破裂的腦動脈瘤，即每 50 人中就有 1 人患有未破裂腦動脈瘤。年破裂率約為每 10 萬人 8 - 10 例。美國每年約有 3 萬人遭受腦動脈瘤破裂。腦動脈瘤每 18 分鐘就會破裂一次。全球每年有近50萬人因腦動脈瘤死亡，其中一半的受害者年齡在50歲以下。

嚴格的監管要求

嚴格的監管要求等因素預計將阻礙全球動脈瘤夾市場。由於衛生當局實施嚴格的監管標準，全球動脈瘤夾市場面臨相當大的障礙。美國FDA和歐洲EMA等監管機構對包括動脈瘤夾在內的醫療器材的安全性和有效性提出了嚴格的要求。這些法規要求在新產品推向市場之前進行全面的臨床測試和詳細的文件記錄。這些核准流程的複雜性和冗長可能會抑制創新並延遲潛在有用產品的發布。高成本、冗長的授權程序以及與合規性相關的不確定性可能會阻礙創新並限制製造商的市場機會，特別是那些資源有限的製造商。

Aneurysm clips are specialized surgical devices used to treat brain aneurysms, which are bulges caused by damaged blood arteries in the brain. These clips are normally composed of titanium and are intended to be inserted across the neck of an aneurysm during a surgical procedure known as aneurysm clipping. The fundamental function of these clips is to isolate the aneurysm from normal blood flow, effectively closing it off and preventing it from filling with blood. This operation is critical because a ruptured aneurysm can cause serious consequences, such as hemorrhagic stroke, which increases the risk of death or lifelong disability.

The major driving forces global aneurysm clips market are due to increased demand for the clips in surgical operations, increasing prevalence of cerebral aneurysms and the usage of improved titanium alloys in the clips. Additionally, the clips have a thin blade shape and are MRI compatible, protecting tissue integrity. Although aneurysm clipping procedure has shown to be safe and effective in treating aneurysms, it is an invasive procedure that requires general anesthesia and dissection of the skull for the procedure.

Market Dynamics: Drivers & Restraints

Increasing prevalence of cerebral aneurysms

The increasing prevalence of cerebral aneurysms is expected to be a significant factor in the growth of the global aneurysm clips market. The increasing prevalence of cerebral aneurysms is expected to have a significant effect on the growth of the global aneurysm clips market. Cerebral aneurysms, which are defined by localized dilations in the blood arteries of the brain, pose serious health hazards, including the possibility of rupture and subsequent hemorrhage. As people become more aware of these concerns, and medical technology advances, the need for effective treatment options like aneurysm clips is projected to rise. With a growing elderly population and increased lifestyle-related health conditions contributing to greater incidence rates, in addition to technological advancemens in surgical equipment, demand for aneurysm clips is projected to increase significantly in the future years.

The increasing prevalence of cerebral aneurysms is the major factor that is driving the market. For instance, according to the Brain Aneurysm Foundation, an estimated 6.8 million people in the United States have an unruptured brain aneurysm, or 1 in 50 people. The annual rate of rupture is approximately 8 - 10 per 100,000 people. About 30,000 people in the United States suffer a brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes. There are almost 500,000 deaths worldwide each year caused by brain aneurysms, and half the victims are younger than 50. So, as a result of rise in the aneurysms, the demand for the aneurysm clips increases and drives the market.

Stringent regulatory requirements

Factors such as stringent regulatory requirements are expected to hamper the global aneurysm clips market. The global aneurysm clips market confronts considerable obstacles as health authorities apply severe regulatory standards. Regulatory authorities, such as the FDA in the United States and the EMA in Europe, set strict requirements for the safety and efficacy of medical devices, including aneurysm clips. These regulations require comprehensive clinical testing and detailed documentation before new products can be introduced to the market. The complexity and length of these approval processes can stifle innovation and delay the release of potentially helpful products. The high costs, lengthy authorization procedures, and uncertainties associated with compliance can hamper innovation and limit the market opportunity for manufacturers, particularly those with limited resources.

Segment Analysis

The global aneurysm clips market is segmented based on material type, aneurysm type, end-user and region.

Titanium based aneurysm clips segment is expected to dominate the global aneurysm clips market share

Titanium based aneurysm clips segment is expected to dominate the global aneurysm clips market share. The titanium-based aneurysm clips segment is expected to dominate the global aneurysm clip market due to a number of compelling features that highlight the material's distinct advantages. This dominance can be due to titanium's inherent characteristics, which make it ideal for medical uses, notably in neurosurgery. One of the key reasons for using titanium aneurysm clips is their biocompatibility.

Titanium is known for its inertness and non-reactivity, which reduces the possibility of negative reactions when implanted in the human body. This feature is critical in surgical situations because the clips must securely occlude blood arteries without triggering irritation or rejection by the body. In addition, the compatibility with imaging modalities, mainly CT scans, MRI, and X-rays, and its capability to effectively secure the closure of delicate vessels during treatment makes it a preferred option as surgical equipment, thus propelling the growth of the segment.

North America is expected to hold a significant position in the global aneurysm clips market share

North America is expected to maintain its dominant position in the global aneurysm clips market share. This position of prominence is primarily due to a combination of factors, including modern healthcare infrastructure, high aneurysm incidence rates, and significant investments in R&D. The region's well-established medical institutions are supplied with advanced equipment and competent workers, allowing for the widespread use of breakthrough surgical procedures and devices like aneurysm clips. For instance, according to the Brain Aneurysm Foundation, an estimated 6.8 million people in the United States have an unruptured brain aneurysm, or 1 in 50 people. African-Americans and Hispanics are about twice as likely to have a brain aneurysm rupture compared to caucasians.

Research and innovation are critical in sustaining North America's dominant position in the aneurysm clip business. The National Institutes of Health (NIH) has provided major capital for cerebrovascular disease research, which is likely to result in advances in aneurysm clip technology. These advancements not only improve therapeutic efficacy and safety, but also coincide with the emerging trend of minimally invasive surgical methods that are less traumatic to patients.

Asia Pacific is growing at the fastest pace in the global aneurysm clips market

Asia Pacific is experiencing the fastest growth in global aneurysm clips owing to the increasing incidence of brain aneurysms and technological advancements in the region. Technological innovations play an important part in moving the Asia Pacific aneurysm clips market ahead. Aneurysm removal procedures are now more effective and safer due to advances in surgical techniques and materials. The emergence of less invasive procedures has made surgery less stressful for patients while also improving recovery times. These developments are especially advantageous in densely populated areas, where access to surgical care can be limited. The increasing prevalence of brain aneurysms is also one of the major driving factor. For instance, according to an article published in the Times of India, India reports somewhere around 76,500 to 204,100 new cases of brain aneurysms every year.

Competitive Landscape

The major global players in the global aneurysm clips market include Boston Scientific, Medtronic, St. Jude Medical, Codman & Shurtleff, KLS Martin Group, InoMed, Integra LifeSciences, Mizuho America, Stryker Corporation, B Braun, RauMedic among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global aneurysm market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Material Type
3.2. Snippet by Aneurysm Type
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Cerebral Aneurysms
- 4.1.2. Restraints
  - 4.1.2.1. Stringent Regulatory Requirements
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Material Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 6.1.2. Market Attractiveness Index, By Material Type
6.2. Titanium*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Cobalt
6.4. Others

7. By Aneurysm Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
- 7.1.2. Market Attractiveness Index, By Aneurysm Type
7.2. Cerebral*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Thoracic
7.4. Abdominal
7.5. Peripheral

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals and Clinics*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Research Centers
8.4. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Aneurysm Type
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Boston Scientific*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Medtronic
11.3. St. Jude Medical
11.4. Codman & Shurtleff
11.5. KLS Martin Group
11.6. InoMed
11.7. Integra LifeSciences
11.8. Mizuho America
11.9. Stryker Corporation
11.10. B Braun

LIST NOT EXHAUSTIVE